NFKB1 and diabetic kidney disease: MiR-423-5p may also affect the activity of NF-κB, resulting in increased expression of proinflammatory cytokines including TNF-α and IL-6, thereby intensifying renal inflammation, promoting cellular injury, and accelerating DKD progression [24].